MCBVX | MVCAX | MCBVX / MVCAX | |
Total Expense Ratio | 1.74 | 0.99 | 176% |
Annual Report Gross Expense Ratio | 1.75 | 1.00 | 175% |
Fund Existence | 24 years | 24 years | - |
Gain YTD | 2.860 | 3.325 | 86% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.1B | 17.1B | 100% |
Annual Yield % from dividends | 0.00 | 0.86 | - |
Returns for 1 year | -4.81 | -3.52 | 137% |
Returns for 3 years | 4.38 | 6.81 | 64% |
Returns for 5 years | 41.77 | 47.65 | 88% |
Returns for 10 years | 50.76 | 63.09 | 80% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NVOH | 28.34 | 0.63 | +2.28% |
NOVO NORDISK A/S (B SHARES) ADRHEDGED NVOH | |||
FTXH | 27.57 | 0.21 | +0.79% |
First Trust Nasdaq Pharmaceuticals ETF | |||
JTEK | 85.28 | 0.50 | +0.59% |
JPMorgan U.S. Tech Leaders ETF | |||
HIO | 3.94 | -0.02 | -0.51% |
Western Asset High Income Opportunity Fund | |||
IEZ | 17.59 | -0.21 | -1.18% |
iShares US Oil Equipment & Services ETF |